| Primary |
| Gout |
63.2% |
| Drug Level |
10.5% |
| Immunosuppression |
10.5% |
| Blood Pressure Increased |
5.3% |
| Gouty Arthritis |
5.3% |
| Hypertension |
5.3% |
|
| Rocky Mountain Spotted Fever |
15.4% |
| Thrombocytopenia |
15.4% |
| Blood Creatinine Increased |
7.7% |
| Blood Urine |
7.7% |
| International Normalised Ratio Abnormal |
7.7% |
| Nephrotic Syndrome |
7.7% |
| Pain In Extremity |
7.7% |
| Renal Failure |
7.7% |
| Somnolence |
7.7% |
| Transient Ischaemic Attack |
7.7% |
| Tremor |
7.7% |
|
| Secondary |
| Gout |
18.3% |
| Product Used For Unknown Indication |
16.9% |
| Asthma |
9.9% |
| Acute Myeloid Leukaemia |
5.6% |
| Cytomegalovirus Infection |
5.6% |
| Drug Use For Unknown Indication |
5.6% |
| Graft Versus Host Disease |
5.6% |
| Nephropathy Toxic |
5.6% |
| Synovitis |
4.2% |
| Anaemia Haemolytic Autoimmune |
2.8% |
| Atrial Fibrillation |
2.8% |
| Cardiomyopathy |
2.8% |
| Gastritis |
2.8% |
| Schizophrenia |
2.8% |
| Adenovirus Infection |
1.4% |
| Angina Pectoris |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Diabetes Mellitus |
1.4% |
| Drug Therapy |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
|
| Myelodysplastic Syndrome |
13.6% |
| Thrombocytopenia |
13.6% |
| Rash |
9.1% |
| Blood Creatinine Increased |
4.5% |
| Dizziness |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Gastrointestinal Haemorrhage |
4.5% |
| Joint Range Of Motion Decreased |
4.5% |
| Pain In Extremity |
4.5% |
| Paraesthesia |
4.5% |
| Pyrexia |
4.5% |
| Renal Failure Acute |
4.5% |
| Therapeutic Response Decreased |
4.5% |
| Transient Ischaemic Attack |
4.5% |
| Urine Colour Abnormal |
4.5% |
| Weight Increased |
4.5% |
| White Blood Cell Count Increased |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.2% |
| Drug Use For Unknown Indication |
13.1% |
| Systemic Lupus Erythematosus |
9.4% |
| Hypertension |
7.6% |
| Gout |
7.1% |
| Hiv Infection |
6.7% |
| Prophylaxis |
4.8% |
| Pain |
3.9% |
| Asthma |
2.5% |
| Hypersensitivity |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Hypothyroidism |
2.2% |
| Depression |
2.1% |
| Atrial Fibrillation |
2.0% |
| Osteoporosis |
1.9% |
| Diarrhoea |
1.8% |
| Non-hodgkin's Lymphoma |
1.8% |
| Premedication |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Colon Cancer |
1.6% |
|
| Weight Decreased |
18.3% |
| Progressive Multifocal Leukoencephalopathy |
9.2% |
| Respiratory Failure |
9.2% |
| Myocardial Infarction |
7.7% |
| Renal Failure Acute |
5.6% |
| Paraesthesia |
4.9% |
| Vomiting |
4.2% |
| Drug Ineffective |
3.5% |
| Flushing |
3.5% |
| Ill-defined Disorder |
3.5% |
| Pruritus |
3.5% |
| Staphylococcal Infection |
3.5% |
| Weight Increased |
3.5% |
| Local Swelling |
2.8% |
| Myalgia |
2.8% |
| Mycobacterium Avium Complex Immune Restoration Disease |
2.8% |
| Nausea |
2.8% |
| Oedema Peripheral |
2.8% |
| Pain In Extremity |
2.8% |
| Pancreatitis |
2.8% |
|
| Interacting |
| Gout |
75.0% |
| Smoking Cessation Therapy |
25.0% |
|
| Myalgia |
50.0% |
| Nausea |
50.0% |
|
